Literature DB >> 17563843

Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis.

Innocenzo Rainero1, Elisa Rubino, Walter Valfrè, Salvatore Gallone, Paola De Martino, Erika Zampella, Lorenzo Pinessi.   

Abstract

The objective of this study was to investigate the association between polymorphisms of the hypocretin receptor 2 gene (HCRTR2) and the risk of cluster headache (CH). The study is a meta-analysis of published case-control studies investigating the association between polymorphisms of the HCRTR2 gene and CH. Pooled odds ratios (OR) were estimated using both random (RE) and fixed effects (FE) models. Three studies, performed in five different European countries, with 593 cases and 599 controls, were included in the study. Allele G of the G1246A HCRTR2 polymorphism was significantly associated with CH (FE OR 1.58, CI 95% 1.27-1.95; RE OR 1.55 (1.14-2.12)). Carriers of the GG genotype showed a higher disease risk compared to the remaining genotypes (FE OR 1.75, CI 95% 1.37-2.25; RE OR 1.69, CI 95% 1.11-2.58). Our data confirm that the G1246A polymorphism of the HCRTR2 gene may modulate the genetic risk for CH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563843      PMCID: PMC3476142          DOI: 10.1007/s10194-007-0383-x

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  25 in total

1.  Increased familial risk of cluster headache.

Authors:  M Leone; M B Russell; A Rigamonti; A Attanasio; L Grazzi; D D'Amico; S Usai; G Bussone
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

2.  Orexin-A, an hypothalamic peptide with analgesic properties.

Authors:  S Bingham; P T Davey; A J Babbs; E A Irving; M J Sammons; M Wyles; P Jeffrey; L Cutler; I Riba; A Johns; R A Porter; N Upton; A J Hunter; A A Parsons
Journal:  Pain       Date:  2001-05       Impact factor: 6.961

3.  A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort.

Authors:  L Baumber; C Sjöstrand; M Leone; H Harty; G Bussone; J Hillert; R C Trembath; M B Russell
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

Review 4.  The physiological role of orexins.

Authors:  Lidia Martynska; Ewa Wolinska-Witort; Magdalena Chmielowska; Wojciech Bik; Boguslawa Baranowska
Journal:  Neuro Endocrinol Lett       Date:  2005-08       Impact factor: 0.765

5.  The orexin OX1 receptor regulates Ca2+ entry via diacylglycerol-activated channels in differentiated neuroblastoma cells.

Authors:  Johnny Näsman; Genevieve Bart; Kim Larsson; Lauri Louhivuori; Hanna Peltonen; Karl E O Akerman
Journal:  J Neurosci       Date:  2006-10-18       Impact factor: 6.167

6.  Familial cluster headache: a series of 186 index patients.

Authors:  Mohammed El Amrani; Anne Ducros; Pauline Boulan; Saadia Aidi; Isabelle Crassard; Jean Marc Visy; Elisabeth Tournier-Lasserve; Marie Germaine Bousser
Journal:  Headache       Date:  2002 Nov-Dec       Impact factor: 5.887

Review 7.  Pathophysiology of cluster headache: a trigeminal autonomic cephalgia.

Authors:  Peter J Goadsby
Journal:  Lancet Neurol       Date:  2002-08       Impact factor: 44.182

8.  Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene.

Authors:  M Schürks; T Kurth; I Geissler; G Tessmann; H-C Diener; D Rosskopf
Journal:  Neurology       Date:  2006-03-22       Impact factor: 9.910

Review 9.  The physiology and pharmacology of the orexins.

Authors:  Darren Smart; Jeffrey Jerman
Journal:  Pharmacol Ther       Date:  2002 Apr-May       Impact factor: 12.310

Review 10.  Genetics of cluster headache: an update.

Authors:  Lorenzo Pinessi; Innocenzo Rainero; Chiara Rivoiro; Elisa Rubino; Salvatore Gallone
Journal:  J Headache Pain       Date:  2005-09       Impact factor: 7.277

View more
  19 in total

1.  Population-Based Analysis of Cluster Headache-Associated Genetic Polymorphisms.

Authors:  Martha-Spyridoula Katsarou; Maria Papasavva; Rozana Latsi; Ioanna Toliza; Alfrent-Pantelis Gkaros; Stylianos Papakonstantinou; Stylianos Gatzonis; Dimos-Dimitrios Mitsikostas; Leda Kovatsi; Boris N Izotov; Aristides M Tsatsakis; Nikolaos Drakoulis
Journal:  J Mol Neurosci       Date:  2018-06-29       Impact factor: 3.444

Review 2.  Licit and illicit drug use in cluster headache.

Authors:  Amelie Govare; Elizabeth Leroux
Journal:  Curr Pain Headache Rep       Date:  2014-05

Review 3.  Genetics of cluster headache.

Authors:  Markus Schürks
Journal:  Curr Pain Headache Rep       Date:  2010-04

4.  Radiosynthesis and evaluation of [11C]EMPA as a potential PET tracer for orexin 2 receptors.

Authors:  Changning Wang; Christian K Moseley; Stephen M Carlin; Colin M Wilson; Ramesh Neelamegam; Jacob M Hooker
Journal:  Bioorg Med Chem Lett       Date:  2013-04-02       Impact factor: 2.823

5.  Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.

Authors:  P Malherbe; E Borroni; L Gobbi; H Knust; M Nettekoven; E Pinard; O Roche; M Rogers-Evans; J G Wettstein; J-L Moreau
Journal:  Br J Pharmacol       Date:  2009-04       Impact factor: 8.739

Review 6.  Sleep and headache.

Authors:  K C Brennan; Andrew Charles
Journal:  Semin Neurol       Date:  2009-09-09       Impact factor: 3.420

Review 7.  Neurobiology and sleep disorders in cluster headache.

Authors:  Mads Christian Johannes Barloese
Journal:  J Headache Pain       Date:  2015-08-20       Impact factor: 7.277

8.  Cluster headache: a quasi-rare disorder needing a reappraisal.

Authors:  Paolo Martelletti; Dimos-Dimitrios Mitsikostas
Journal:  J Headache Pain       Date:  2015-06-26       Impact factor: 7.277

Review 9.  Cluster headache.

Authors:  Elizabeth Leroux; Anne Ducros
Journal:  Orphanet J Rare Dis       Date:  2008-07-23       Impact factor: 4.123

10.  Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies.

Authors:  Daisuke Nishizawa; Shinya Kasai; Junko Hasegawa; Naomi Sato; Hidetaka Yamada; Fumihiko Tanioka; Makoto Nagashima; Ryoji Katoh; Yasuo Satoh; Megumi Tagami; Hiroshi Ujike; Norio Ozaki; Toshiya Inada; Nakao Iwata; Ichiro Sora; Masaomi Iyo; Mitsuhiko Yamada; Naoki Kondo; Moo-Jun Won; Nobuya Naruse; Kumi Uehara-Aoyama; Masanari Itokawa; Kazutaka Ohi; Ryota Hashimoto; Kumpei Tanisawa; Tomio Arai; Seijiro Mori; Motoji Sawabe; Makiko Naka-Mieno; Yoshiji Yamada; Miki Yamada; Noriko Sato; Masaaki Muramatsu; Masashi Tanaka; Yoko Irukayama-Tomobe; Yuki C Saito; Takeshi Sakurai; Masakazu Hayashida; Haruhiko Sugimura; Kazutaka Ikeda
Journal:  Mol Brain       Date:  2015-08-20       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.